Cardiovascular disease (CVD) is the leading cause of death worldwide. There are
numerous factors involved in the development of CVD. Among these, lipids have an …

Chronic systemic inflammation is associated with an increased risk of cardiovascular
disease in an environment of low low-density lipoprotein (LDL) and low total cholesterol and …

Oxidized phospholipids (OxPLs) promote inflammation as well as low density lipoprotein
(LDL) uptake in a variety of physiological and pathological states. Given the anti …

Abstract Doxorubicin (Dox)-induced cardiotoxicity, a limiting factor in the use of Dox to treat
cancer, can be mitigated by the mitogenic factor FGF2 in vitro, via a heme oxygenase 1 (HO …

Phospholipids (PLs), which are of diverse chemical structures, are not only the major
component of the plasma membranes, but also act as signaling mediators for various …

A mixture of native and oxidized phospholipids (PLs), generated by the soybean
lipoxygenase type V-catalyzed partial oxidation of a lipid extract obtained from human …

Inflammatory mediators play an important role in the pathogenesis of several diseases
including heart failure. An appropriate balance between pro-inflammatory and anti …

Long thought of as a bystander in pathophysiological processes, lipid molecules have
emerged as bioactive mediators of cellular activity. Oxidized phospholipids (OxPLs) …

Doxorubicin (DOX) is an effective anthracycline anti-neoplastic agent used for the treatment
of hematological and solid tumors. Advancements in cancer treatment over several decades …

Chlorinated propanols are processing induced food contaminants formed in the
manufacturing of vegetable oils and hydrolyzed vegetable protein. The 2-monochloro …